Safety and Efficacy of Adjunct Dexamethasone in Adults with Herpes Simplex Virus Encephalitis in The UK - Part 1
<p>In part one of this series, Dr. Aaron Zelikovich discusses the trial design and primary results. </p> <p>Show citation: </p> <p>Solomon T, Hooper C, Easton A, et al. Safety and efficacy of adjunct dexamethasone in adults with herpes simplex virus encephalitis in the UK (DexEnceph): a multicentre, observer-blind, randomised, phase 3, controlled trial. <em>Lancet Neurol</em>. 2026;25(2):136-146. doi:<a href= "https://linkinghub.elsevier.com/retrieve/pii/S1474442225004545" target="_blank" rel= "noopener">10.1016/S1474-4422(25)00454-5 </a></p> <p>Show transcript: </p> <p>Dr. Aaron Zelikovich: </p> <p>Welcome to today's Neurology Minute. My name is Aaron Zelikovich. …
Deze aflevering is nog niet getranscribeerd.
Gebruik STT.ai om deze aflevering te transcriberen met AI. Krijg nauwkeurige tekst met luidsprekerdetectie, tijdstempels en export in meerdere formaten.